4 Mg Lenvatinib Capsules

Name: 4 Mg Lenvatinib Capsules
Brand: NEETCO BIOPHARMA
Price: 1700 INR
Availability: InStock

Price 1700 INR/ Box

Get a Price/Quote

MOQ : 1 Box

4 Mg Lenvatinib Capsules Specification

Salt Composition
Lenvatinib 4 mg

Indication
Treatment of thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, and other selected solid tumors

Dosage Form
Hard Gelatin Capsules

Feature
Targeted therapy, multi-kinase inhibitor, high oral bioavailability

Ingredients
Lenvatinib mesylate, excipients; capsule shell (gelatin, titanium dioxide, coloring agents)

Application
Oral administration only for prescription use

Physical Color/Texture
Yellowish-white powder filled in white hard gelatin capsule

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months from the date of manufacture

Adverse Effects
Hypertension, fatigue, diarrhea, decreased appetite, weight loss, proteinuria

Prescription/Non-Prescription
Prescription only medicine

Storage Humidity
Store in a dry place

Product Form
Solid Capsule

Therapeutic Class
Antineoplastic Agents

Warning
To be sold by retail on the prescription of an oncologist only

Administration Route
Oral

ATC Code
L01XE38

Packaging Type
Blister strip in a carton box

Strength
4 mg per capsule

Container Material
PVC/PVDC-Aluminium blister

About 4 Mg Lenvatinib Capsules

Discover a hot deal on 4 mg Lenvatinib Capsules, offered at an unbeatable price from top-tier exporters and distributors in India. These pristine, prescription-only hard gelatin capsules embody a pivotal breakthrough in targeted antineoplastic therapy for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. Boasting lofty therapeutic efficacy, each capsule contains Lenvatinib mesylate and essential excipients. Assembled in secure blister strips and carton boxes for optimal safety, this product ensures high oral bioavailability and must be used only on the advice of an oncologist. Buy now, as per prescription, for assured clinical outcomes.

Application and Use of 4 Mg Lenvatinib Capsules

4 mg Lenvatinib Capsules are designed for oral administration, targeting pivotal pathways in thyroid, kidney, and liver cancers. The capsule's pristine formulation ensures stable surface quality, being filled with a yellowish-white powder in a white hard gelatin shell, suitable for adult patients under oncologist supervision. The application method requires swallowing the capsule whole, once daily or as prescribed. This product is suitable for use strictly on a physician's recommendation, making it essential for controlled therapeutic protocols.

Packaging, Export Market, and Supply Ability

These Lenvatinib Capsules come in a lofty-quality PVC/PVDC-Aluminium blister strip, securely packed within carton boxes for protection during storage and transport. Our export market includes reliable, swift delivery across regions, with sample policies in place for institutional inquiries. The sale price reflects both the product's efficacy and pristine packaging. Supply ability is tailored for distributors, suppliers, and traders, ensuring consistent, high-volume availability. Experience seamless delivery and support for bulk and export orders from India.

FAQ's of 4 Mg Lenvatinib Capsules:

Q: How should 4 Mg Lenvatinib Capsules be administered?

A: The capsules should be swallowed whole with water, strictly as per the prescription and guidance of an oncologist. Do not chew, crush, or open the capsule.

Q: What cancers are these capsules indicated for?

A: 4 Mg Lenvatinib Capsules are approved for the treatment of thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, and selected other solid tumors.

Q: Where should I store the capsules to maintain their effectiveness?

A: Store the capsules below 30C, in a dry place, and protect them from moisture and light to preserve their potency and shelf life.

Q: When is it appropriate to buy and start using 4 Mg Lenvatinib Capsules?

A: Only purchase and begin taking these capsules after obtaining a prescription from a qualified oncologist who has determined their suitability for your condition.

Q: What are the potential adverse effects of using Lenvatinib?

A: Patients may experience hypertension, fatigue, diarrhea, decreased appetite, weight loss, or proteinuria. Always report any side effects promptly to your healthcare provider.

Q: How is the product packaged for export markets and retail sale?

A: Each capsule is individually sealed in a PVC/PVDC-Aluminium blister strip, which is then packed in a sturdy carton box to ensure protection during delivery and storage, especially for export markets.

Tell us about your requirement